You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Recent awards include:
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at S&P Capital IQ Pro or S&P Capital IQ .
Emergent BioSolutions CEO to retire; replacement named
S&P Capital IQ Pro | Unrivaled Sector Coverage
S&P Capital IQ Pro | Powering Your Edge
Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud
Insight Weekly: Labor market struggles; solar demand remains strong; banks' deposit holdings
Emergent BioSolutions Inc. said Daniel Abdun-Nabi is retiring as the company's CEO and board member.
Abdun-Nabi has been the company's CEO since April 2012.
Robert Kramer, the company's current president and COO, will replace Abdun-Nabi. Effective April 1, Kramer will assume the president and CEO roles. He will also assume Abdun-Nabi's board seat.
Gaithersburg, Md.-based Emergent BioSolutions is a life sciences company developing specialty products to address public health threats.